This Pharmaceutical Giant Just Poured $11B — Time to Buy?
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
This article explains the main drivers of stock index performance and how various factors influence broad market moves. It helps readers understand signals behind daily swings and long-term trends.
20,153 articlesA major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Boone Capital just disclosed a fresh position in HealthEquity, raising questions about the stock's potential. This gu...
When top executives trim stakes, investors take note. This article breaks down the meaning behind such moves, with a ...
On a day when markets slid on inflation fears, one small-cap stock surprised investors by rocketing higher. Here’s wh...
Two fintech giants sit at the center of modern investing. This guide breaks down Coinbase Global and Robinhood Market...
Thinking about investing in artificial intelligence stocks hold for the long run? This article breaks down two depend...
A top executive at Rush Street Interactive disclosed a sizable stock sale following a strong earnings report. This ar...
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Rocket Lab is pursuing a bold $8 billion strategy to merge rocket launches, satellites, and data services. Learn what...
AppLovin reported its best quarter in history, with record revenue and an 84% EBITDA margin, but the stock declined s...
Micron Technology’s shares advanced again as investors eye a $500 billion market-cap milestone, building on a rapid c...
A major fund just raised its stake in a leading data-center company. This article breaks down what that move could me...